The Week in Review: March 2 – March 9, 2018

Friday, March 9, 2018 News Recap: Canada: Northern Vancouver Island VIRAL HEPATITIS Outreach Roadshow Trip 2018 – March 12 – 21, 2018. We are happy to announce that a 10-day roadtrip to northern Vancouver Island is just around the corner! We will be bringing hot-off-the-press posters, pamphlets, and audio-visual resources to community organizations and Friendship Centres, band health centres, and health clinics. See links to some of the resources we...

Japan: Couple held over bogus hepatitis C drug served fresh warrant over fake Harvoni tablets

A couple were arrested anew on suspicion of selling a counterfeit version of the hepatitis C drug Harvoni to a wholesaler. The Metropolitan Police Department arrested Yoshimi Kase, 49, and her husband, Takayuki, 43, on suspicion of violating the pharmaceuticals and medical devices law. The two, who had already been indicted for the use of illegal drugs, denied the fresh allegations and claimed their products were genuine, according to investigative sou

Japan: Hepatitis C drug fakes found in Nara drugstore chain

This is scary!! If this happens in Japan, could it happen in Canada or the USA? Counterfeits of the hepatitis C drug Harvoni have been found at a drugstore chain in Nara Prefecture, the health ministry said Tuesday. Harvoni is sold by a Japanese unit of U.S. pharmaceutical firm Gilead Sciences Inc. The ingredients of the counterfeits are now under examination. The ministry and Gilead are calling on patients, doctors and pharmacists to beware of

Japan’s PMDA reviews hep B risk link to hep C therapies

Japan's Pharmaceuticals and Medical Devices Agency (PMDA) is reviewing approved hepatitis C drugs in the country for links to a possible reactivation of the hepatitis B virus, which could result in label changes. In a notice last week, PMDA said that the review covers Gilead Sciences' ($GILD) Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) as well as AbbVie's ($ABBV) Viekirax (ombitasvir and paritaprevir and ritonavir), Bristol-Myers Squibb...